Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women-Reference-Cited by-同舟云学术

Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women

Published:2017-07 Issue:1 Volume:146 Page:34-38
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Baker William D.,Pierce Stuart R.,Mills Anne M.,Gehrig Paola A.,Duska Linda R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference26 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study;Persson;BMJ,1989

3. Endometrial cancer in young, normal-weight women;Schmeler;Gynecol. Oncol.,2005

4. Understanding obesity and endometrial cancer risk: opportunities for prevention;Schmandt;Am. J. Obstet. Gynecol.,2011

5. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review;Kaaks;Cancer Epidemiol. Biomark. Prev.,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suture fixation of the levonorgestrel-releasing intrauterine device with hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion;2023-12-11

2. Age as a Predictor of Time to Response for Patients Undergoing Medical Management of Endometrial Cancer;Clinical Journal of Obstetrics and Gynecology;2023-10-04

3. An Overview of Endometrial Cancer with Novel Therapeutic Strategies;Current Oncology;2023-08-27

4. Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis;Journal of Gynecologic Oncology;2023

5. Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023